baber/WOPTO huggingface dataset:
Patent AT-E195038-T1 (AT)
Inventor: VANKOV MICHAEL
IPC: H01R4/18
Filed: 1996-11-02
Granted: 2000-08-15
Abstract: The invention relates to a contact for at least one electrical conductor, especially a heating wire (26) in a device for personal use, like a hair-drier, a curl brush, a kitchen appliance or the like, consisting of a basic body (4) with at least one contact surface to connect and a clamp (8) to secure the electrical conductor (26) and a process for securing the heating wire (26) to the contact (2). Here, the clamp (8) exhibits a material bond with the electrical conductor by the application of heat, especially a soldered bond.
Patent AT-E260340-T1 (AT)
Inventor: DAVIS SAMUEL
IPC: C12N15/09
Filed: 1996-11-01
Granted: 2004-03-15
Abstract: This invention concerns the molecular cloning and characterization of nucleic acids encoding molecules, referred to as relaxin-related factors, that are related to the hormone relaxin and to the insulin family of ligands. More specifically, this invention provides an isolated nucleic acid molecule encoding relaxin-related factor-1. The invention also provides an isolated nucleic acid molecule encoding relaxin-related factor-2. The present invention also provides a nucleotide sequence that encodes a relaxin-related factor, as well as cells which are genetically engineered to produce the relaxin-related factor. The invention further provides for an isolated relaxin-related factor substantially free of other proteins, as well as for an antibody which specifically binds the relaxin-related factor. The invention also provides for pharmaceutical compositions comprising a relaxin-related factor, or an antibody which specifically binds the relaxin-related factor, and a pharmaceutically acceptable carrier, as well as for methods of treatment of a human or animal body. The invention further provides for a relaxin-related factor ligandbody which comprises a relaxin-related factor fused to an immunoglobulin constant region. The invention further provides for a method of treatment comprising administering a relaxin-related factor ligandbody to a human or animal body.
Patent AT-E253960-T1 (AT)
Inventor: HUSTED ROYCE H
IPC: A63B21/008
Filed: 1996-12-13
Granted: 2003-11-15
Abstract: An exercise device that simulates a striding action includes a base. Four linkages support two independently swingable side-by-side foot platforms from spaced apart front and rear supports secured to uprights that are connected to the base. The front and rear supports are positioned with respect to the foot platforms to substantially match the swing length of a person's leg. The distance between the front and rear supports is less than the distance between the front and rear pivots on the foot platforms. Outwardly extending handles are integral with the foot, platforms and are spaced farther apart than the distance between the foot platforms. The rear of each foot platform is slightly elevated with respect to its front.
Patent AT-E204114-T1 (AT)
Inventor: GROSS MARTIN
IPC: H05B3/00
Filed: 1997-01-18
Granted: 2001-08-15
Abstract: A sensor (30) has a single-wind loop that consists of a tube or thick wire and fits over the sensor near heater zones (18,19) and tightly under a glass ceramic plate. In the case of a two-circuit electric radiant element, the sensor loop is shaped in the heater zones with concise peripheral areas (37,38).  An Independent claim is also included for a radiant element.
Patent AT-E205432-T1 (AT)
Inventor: GRENZ GUENTER
IPC: B21B15/00
Filed: 1997-03-07
Granted: 2001-09-15
Abstract: Cropping and handling the head and/or tail crop ends of rolled strands on the run with a rotary cutter (1) or parallel shear, comprises passing the strand to the cutter (1) through a swing guide (11) with a given alignment relative to the rolling line (x-x) and, after measurement by a distance transducer, the head and/or tail end is parted by the cutter (1), the outgoing strand is lifted over the separating wedge (13) of a following diverter (12) and the parted head or tail piece is diverted into a scrap chute (3) or to cut-up shears (5) via the separating wedge (13) of the diverter (12). Also claimed is the apparatus for the above process.
Patent AT-E232073-T1 (AT)
Inventor: FEBO PIETRO
IPC: A61F13/53
Filed: 1997-04-30
Granted: 2003-02-15
Abstract: The present invention relates to individual layered structures for use in a disposable absorbent article comprising a particulate material contained between containing layers, at least one of the layers being permeable to liquids. The individual layered structure is cut from a larger structure and is joined along at least along part of the cut, and further has end surfaces along said cuts. The individual layered structure comprises at least one patch of material applied along at least part of the end surfaces, wherein the at least one patch of material providing the containing layers with joining means in the at least part of the end surfaces where it is applied. The invention further relates to a process for manufacturing the individual layered structures by cutting them from a larger structure, and then providing them with at least one patch of material applied along at least part of the end surfaces formed along the cut. <IMAGE>
Patent AT-E236826-T1 (AT)
Inventor: MUELLER ANTON
IPC: B62H3/00
Filed: 1997-07-25
Granted: 2003-04-15
Abstract: The bicycle stand has a support to which at least one clamping part is attached. The clamping part has a receiver aperture for a bicycle component, e.g. the saddle tube. The clamping part has at least two clamp receiver sectors (47,49) one behind the other in the insertion direction, of different width. The front clamp receiver sector in the insertion direction (47) is wider than the other sector (49). There may be a narrowing (48) between the clamp receiver sectors, forming limiting surfaces (39,410) which in cross-section are partly circular and bent inwards.
Patent AT-E229687-T1 (AT)
Inventor: LEWIS DAVID EARL
IPC: G11B11/10
Filed: 1996-03-19
Granted: 2002-12-15
Abstract: An apparatus for controlling the strength of a magnetic field, comprises a first controller (14), a second controller (15), a digital-to-analog converter (16), a current driver (17), and a bias coil (18). The first controller (14) determines the position of the focal point of a lens (29) and passes it to the second controller (15), which provides a digital signal related to the position. The digital-to-analog converter (16) converts the digital signal to a driver voltage and passes the driver voltage to a current driver (17), which provides to the bias coil (18) a bias current related to the driver voltage. The bias coil (18) produces a magnetic field having a strength related to the bias current. The second controller (15) accounts for stray magnetic fields in creating the digital signal. The stray magnetic fields may be constant or may vary in strength based on position of the objective lens (29), circumferential velocity of the storage medium (2, 4), or longitudinal velocity of the storage medium (2, 4). Furthermore, the apparatus may comprise a current sensor (26) for measuring the bias current, and a feedback device for providing to the current driver (17) a feedback voltage related to the bias current. <IMAGE>
Patent AT-E216502-T1 (AT)
Inventor: REICHERT WERNER DIPL-ING
IPC: G02B5/08
Filed: 1997-11-17
Granted: 2002-05-15
Abstract: The composite material comprises a metal band support (1), an interlayer (2) and a multilayer optical system (3) having a nonmetallic protective layer (4) of low-absorption material with a thickness (D4) of 5-20 nm, preferably 5-10 nm, applied to the optical system.
Patent AT-E230157-T1 (AT)
Inventor: MOESSNER GERHARD DIPL-ING
IPC: H01H71/40
Filed: 1997-12-09
Granted: 2003-01-15
Abstract: The switch has a rotatable switching toggle (14) and a switching lock with a latching position, a thermal and an electromagnetic trigger and a contact position with a fixed and a movable contact piece formed on a contact lever. A guide element (20) movable linearly and perpendicularly wrt. the switch front wall (12) is coupled to the switching toggle via a lever. The thermal and electromagnetic trigger (44,37) act on a pawl lever (22) rotatably mounted on the guide element, which is pivoted against a spring force. The end of a yoke is guided in an elongated hole (27) in the guide element. The other end is coupled to the contact lever (33). The first end is pressed against a protrusion (26) formed on the pawl lever when engaged.
Patent AT-E355528-T1 (AT)
Inventor: KILMER KATHLEEN ELLEN
IPC: G01F23/14
Filed: 1997-01-21
Granted: 2006-03-15
Abstract: An aspirator/dispenser of liquid has a sensor for sensing contact with the liquid by the dispense vessel, which uses constant pressure air expelled out the tip of the dispense vessel. The sensor is improved in that the line of air pressure feeding into the vessel is vented in parallel with the vessel, to the atmosphere, so that the spike of pressure occurring when the vessel encounters the liquid, is released out the vent, rather than the vessel, thus avoiding bubble formation in the liquid. <IMAGE>
Patent AT-E234218-T1 (AT)
Inventor: BOOTHMAN ANDREW JAMES CHRISTOP
IPC: B62D25/10
Filed: 1997-11-26
Granted: 2003-03-15
Abstract: A body panel assembly for eg a tractor engine hood comprises a top panel (8), side panels (12) and a front grille panel (18). Forward ends of the top and side panels are secured to a frame (3) mounted on or integral with the front of the tractor chassis (1). The grille panel (18) is mounted at least partially by releasable means on an alignment member or members (17, 26) whose exact position may be adjusted during the assembly process to ensure accurate alignment of the front grille panel (18) to the side panel (12). <IMAGE>
Patent AT-E327034-T1 (AT)
Inventor: SARUHASHI MAKOTO
IPC: B01D69/08
Filed: 1997-12-24
Granted: 2006-06-15
Abstract: A process for producing a hollow fiber membrane, a hollow fiber membrane, and a dialyzer of hollow fiber membrane type are provided. The hollow fiber membrane is highly biocompatible, and the production process is quite simple and inexpensive. In the process of the invention, the hollow fiber membrane is produced in a system wherein a polymer-containing spinning solution is extruded from a tube-in-tube type orifice of a spinner in a coagulation solution to form the hollow fiber membrane. The polymer-containing spinning solution is extruded from the outer tube of the orifice to form a cylindrical filament having an inner bore and a core solution is ejected from the inner tube of the orifice into the inner bore of the filament for coagulation of the filament. The filament is directly extruded into the coagulation solution or extruded into air and then drawn to the coagulation solution. The core solution is supplemented with a hydrophobic modifier such as vitamin E and a surfactant and the resulting hollow fiber membrane contains the hydrophobic modifier on its inner surface.
Patent AT-E370412-T1 (AT)
Inventor: HAMMERSTEDT ROY
IPC: G01N33/50
Filed: 1997-01-06
Granted: 2007-09-15
Abstract: A purified polypeptide which provides for initial binding of sperm to oocyte investments and has an active amino acid sequence of SEQ ID NO:12 (Cys-Gln-Ser-Leu-Gln-Glu-Tyr-Leu-Ala-Glu-Gln-Asn-Gln-Arg-Gln-Leu-Glu-Ser-Asn-Lys-Ile-Pro-Glu-Val-Asp-Leu-Ala-Arg-Val-Val-Ala-Pro-Phe-Met-Ser-Asn-Ile-Pro-Leu-Leu-Leu-Tyr-Pro-Gln-Asp-Arg-Pro-Arg-Ser-Gln-Pro-Gln-Pro-Lys-Ala-Asn-Glu-Asp-Val-Cys); or SEQ ID NO:13 (Cys-Glu-Ser-Leu-Gln-Lys-His-Leu-Ala-Glu-Leu-Asn-His-Gln-Lys-Gln-Leu-Glu-Ser-Asn-Lys-Ile-Pro-Glu-Leu-Asp-Met-Thr-Glu-Val-Val-Ala-Pro-Phe-Met-Ala-Asn-Ile-Pro-Leu-Leu-Leu-Tyr-Pro-Gln-Asp-Gly-Pro-Arg-Ser-Lys-Pro-Gln-Pro-Lys-Asp-Asn-Gly-Asp-Val-Cys); or the shorter but biologically active SEQ ID NO:1 and SEQ ID NO:9 (Tyr-Pro-Gln-Asp-Arg-X-Arg-Ser-Gln-Pro-Gln-Pro-Lys-Ala-Asn, where X is Thr or Pro). The polypeptide is useful in improving sperm-egg binding by fresh sperm, restoring sperm-egg binding following a cryopreservation cycle, enhancing fertilizing potential, and producing antibodies to determine fertilizing potential of sperm, determining sperm-binding sites on egg investments, and contraception.
Patent AT-E244572-T1 (AT)
Inventor: MEERS PAUL R
IPC: A61K9/127
Filed: 1997-10-15
Granted: 2003-07-15
Abstract: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
Patent AT-E218402-T1 (AT)
Inventor: SUNDHAGEN GUNNAR
IPC: B21D22/06
Filed: 1997-03-21
Granted: 2002-06-15
Abstract: A method and tool for forming convexities (3, 4) in a plate body (1), which plate body (1) comprises a main face (2) and a plurality of side edges. The plate body (1) is inserted between two tool halves (11, 12), which are brought together and interact to press a first set of convexities (3) in a first direction relative to the main face (2) of the plate body (1) and a second set of convexities (4) in a second, opposite direction relative to the main face (2) of the plate body (1). The convexities (3, 4) are formed along a straight line across the plate body (1) between two of the side edges thereof. The plate body (1) is secured so that the main face (2) thereof maintains its orientation, and each of the convexities (3) in the first set of convexities is pressed out by a length (1), measured from one side of the convexities (3) at a point (20) on the main face (2) of the plate body (1) along the convexity (3) to the second side of the convexity (3) at a point (21) on the main face (2) of the plate body (1), which is substantially equal to the corresponding length (1) by which each of the convexities (4) in the second set of convexities is pressed out.
Patent AT-E202848-T1 (AT)
Inventor: KOHL MICHEL
IPC: G01N33/531
Filed: 1997-04-30
Granted: 2001-07-15
Abstract: The invention discloses a method for detecting and/or quantifying a hapten in a homogeneous phase, comprising the following steps: adding a known quantity of a hapten inhibitor complex to the solution containing the hapten to be detected and/or quantified; adding to the solution a quantity of antibodies corresponding to the quantity of the hapten/inhibitor complex; adding to the solution a type C beta-lactamase having an active site for two substrates in antigenic competition in the said active site, the first substrate being a reporter substrate capable of being transformed into a detectable and/or quantifiable product, preferably by visible UV radiation measurement, the second substrate being the hapten/inhibitor complex acting on the hydrolysis rate of the reporter substrate; detecting and/or quantifying the concentration of the product resulting from the transformation of the reporter substrate, the Km constant of the reporter substrate being at least a hundred times higher than the Km constant of the hapten/inhibitor complex, and the kcat constant being at least ten times higher than the Kcat constant of the hapten/inhibitor complex.
Patent AT-E193114-T1 (AT)
Inventor: POULSEN STEEN BLOCK
IPC: B29C63/06
Filed: 1997-06-18
Granted: 2000-06-15
Abstract: The present invention relates to a process for continuous preparation of pipe sections with foil for insulation purposes, wherein an elongated, cylindrical shaped member (4) being slitted in the longitudinal direction is advanced axially, and where a plane foil (1) is shaped to tubular shape which surrounds the shaped member from slit edge to slit edge, and where the foil is made to adhere to the surface of the shaped member. The foil (1) is shaped using shaping tools (6), and without essentially using the shaped member (4) as support in the shaping process.
Patent AT-E216638-T1 (AT)
Inventor: BLUM JOACHIM
IPC: B05D7/00
Filed: 1997-08-14
Granted: 2002-05-15
Abstract: In a process for applying a multilayered coat of lacquer, a priming layer, a base lacquer layer and one or more clear lacquer coatings are applied on a metallic surface that can be autophoretically coated. An intermediate layer can be applied between the priming layer and the base lacquer layer. The priming layer is applied as a first coating layer made of a coating agent that can be autophoretically deposited and is then baked, and the other coating layers are then applied, so that the total dry layer thickness of the multilayered coat of lacquer lies between 80 and 130  mu m and the total dry layer thickness of the clear lacquer layers lies between 40 and 80  mu m.
Patent AT-E224483-T1 (AT)
Inventor: SAND WILLIAM F
IPC: A47L15/44
Filed: 1997-12-05
Granted: 2002-10-15
Abstract: A three-piece air gap eductor includes a molded body having air gap, discharge and venturi sections, a nozzle and a spray shield extending about the venturi section entry to constrain turbulence and reduce backsplash and spray exiting the air gap chamber. A water stream engaging the outer-driven venturi is smoothly divided into respective venturi and bypass streams, with the frustoconical shield capturing turbulent water outside the venturi in a water sheet moving toward a discharge. An improved shield is frustoconically shaped, has an internal reflection shoulder and external moister collecting bars to enhance mist and spray reduction in the air gap section. A V-shaped recess in the shield facilitates its emplacement about the venturi section. The molded body is stiffened to avoid functional misalignment of the water stream between the nozzle and the venturi.
Patent AT-E240736-T1 (AT)
Inventor: BISHOP CHARLES W
IPC: A61K31/59
Filed: 1992-01-07
Granted: 2003-06-15
Abstract: 1 PROPORTIONAL ,24-dihydroxy vitamin D2 which is useful as an active compound of pharmaceutical compositions for the treatment of disorders of calcium metabolism and for various skin disorders. The invention also includes preparation of synthetic 1 PROPORTIONAL ,24-dihydroxy vitamin D2 starting from ergosterol which is converted in six steps to 24-hydroxyergosterol. 24-hydroxyergosterol is irradiated and thermally converted to 24-hydroxy vitamin D2 which is converted in five steps to 1 PROPORTIONAL ,24-dihydroxy vitamin D2. The syntheses also produce novel intermediates. <IMAGE>
Patent AT-E231394-T1 (AT)
Inventor: WATSKY ERIC JACOB
IPC: A61K31/495
Filed: 1998-12-15
Granted: 2003-02-15
Abstract: Use of a compound of formula 1 in the preparation of a medicament for treating a pshcyhiatic condition or disorder selected from dementia, dementia of the Alzheimer's type, anxiety disorders, psychotic episodes of anxiety, anxiety associated with psychosis, mood disorders associated with psychotic disorder, psychotic mood disorders, mood disorders associated with schizophrenia, dyskinesias and behavioral manifestations of mental retardation, conduct disorder and autistic disorder. <CHEM> or a pharmaceutically acceptable acid addition salt thereof, wherein     Ar is benzoisothiazolyl or an oxide or dioxide thereof each optionally substituted by one fluoro, chloro, trifluoromethyl, methoxy, cyano, nitro or napthyl optionally substituted by fluoro, chloro, trifluoromethyl, methoxy, cyano or nitro; quinolyl; 6-hydroxy-8-quinolyl; isoquinolyl; quinazolyl; benzothiazolyl; benzothiadiazolyl; benzoxazolyl; benzotriazolyl; benzoxazolyl; benzoxazolonyl; indolyl; indanyl optionally substituted by one or two fluoro, 3-indazolyl optionally substituted by 1-trifluoromethylphenyl; or phthalazinyl;   n is 1 or 2; and X and Y together with the phenyl to which they are attached form quinolyl; 2-hydroxyquinolyl; benzothiazolyl; 2-aminobenzothiazolyl; benzoisothiazolyl; indazolyl; 2-hydroxyindazolyl, indolyl; spiro; oxindolyl optionally substituted by one to three of (C1-C3)alkyl, or one of chloro, fluoro or phenyl, said phenyl optionally substituted by one chloro or fluoro; benzoxazolyl; 2-aminobenzoxazolyl; benzoxazolonyl; 2-aminobenzoxazolinyl; benzothiazolonyl; benzoimidazolonyl; or benzotriazolyl.
Patent AT-E223522-T1 (AT)
Inventor: ANDOLFATTO FRANCOISE
IPC: C25B1/26
Filed: 1998-12-03
Granted: 2002-09-15
Abstract: An oxygen reduction cathode type membrane electrolysis cell is immobilized by filling the gas compartment with demineralized water of pH ≤ 7. A membrane electrolysis cell, with an oxygen reduction cathode, is immobilized by terminating current and oxygen supply to the cell, filling the emptied gas compartment with demineralized water of pH ≤ 7, rinsing the cathode with the demineralized water of the gas compartment until the pH equals that of the introduced water and keeping the gas compartment filled with the demineralized water throughout the immobilization period. Preferred Feature: The anodic compartment is emptied and refilled with clean anolyte of the same type and concentration and the soda compartment is emptied and refilled with a 0.5-5 mol/l caustic soda solution.
Patent AT-E275963-T1 (AT)
Inventor: MEINZER ARMIN
IPC: A61K38/00
Filed: 1998-01-28
Granted: 2004-10-15
Abstract: The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A, a surfactant of HLB value of at least 10 comprising a polyoxyethylene-sorbitan-fatty acid ester and/or a sorbitan fatty acid ester, and a hydrophilic phase comprising a polyethylene glycol and at least one lower alkanol, wherein each lower alkanol present is present in an amount of less than 12 % of the total weight of the composition disregarding the hard gelatine capsule, the composition being substantially free of any additional oil.
Patent AT-E216390-T1 (AT)
Inventor: BROWN ROGER
IPC: A61K31/519
Filed: 1998-07-15
Granted: 2002-05-15
Abstract: PCT No. PCT/SE98/01394 Sec. 371 Date Sep. 30, 1998 Sec. 102(e) Date Sep. 30, 1998 PCT Filed Jul. 15, 1998 PCT Pub. No. WO99/05144 PCT Pub. Date Feb. 4, 1999Triazolo[4,5-d]pyrimidine compounds of the formula where R1 through R4 and X are as defined in the specification are provided, together with compositions containing them, a process for their preparation and methods of use. The compounds are useful in the treatment of platelet aggregation disorders and angina.
Patent AT-E228998-T1 (AT)
Inventor: CURTIN MICHAEL L
IPC: C07D233/74
Filed: 1998-07-27
Granted: 2002-12-15
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
Patent AT-E243987-T1 (AT)
Inventor: STEINMETZ ROLF
IPC: A61G1/06
Filed: 1998-07-10
Granted: 2003-07-15
Abstract: The invention relates to a device for removably attaching a stretcher (1) to a stretcher trolley (8), comprising at least one but preferably two connecting elements (16) arranged on the stretcher trolley (8) and at least a corresponding number of locking elements (7) arranged on the stretcher (1) which are configured such that they correspond with the connecting elements (16) on the stretcher trolley (8). To improve on such a device in such a way that especially in case of accidents it offers greater safety in an ambulance, the invention provides for the locking elements (7) to be able to lock into the connecting elements (16) automatically and under pressure and for it to be possible to manipulate the connection between the locking elements (7) and the connecting elements (16) so as to detach said elements from each other.